Opportunities for immunotherapy in childhood acute myeloid leukemia.
This article reviews the current landscape of antibody-based and cellular immunotherapies under current clinical evaluation with an emphasis on active or soon-to-open phase 1 trials for children with relapsed/refractory AML.
PMID: 31808843 [PubMed - in process]
Source: Hematology ASH Education Program - Category: Hematology Tags: Hematology Am Soc Hematol Educ Program Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Childhood Cancer | Children | Education | Hematology | Immunotherapy | Leukemia | Stem Cell Therapy | Stem Cells | Toxicology | Transplants | Universities & Medical Training